Abbot Financial Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $577K | Hold |
3,419
| – | – | 0.24% | 99 |
|
|
2025
Q4 | $577K | Sell |
3,419
-25
| -0.7% | -$4.06K | 0.24% | 97 |
|
|
2025
Q3 | $497K | Sell |
3,444
-20
| -0.6% | -$2.73K | 0.21% | 97 |
|
|
2025
Q2 | $438K | Hold |
3,464
| – | – | 0.2% | 103 |
|
|
2025
Q1 | $443K | Sell |
3,464
-228
| -6% | -$30.9K | 0.23% | 101 |
|
|
2024
Q4 | $488K | Sell |
3,692
-225
| -6% | -$31.6K | 0.24% | 100 |
|
|
2024
Q3 | $570K | Hold |
3,917
| – | – | 0.29% | 93 |
|
|
2024
Q2 | $538K | Hold |
3,917
| – | – | 0.29% | 90 |
|
|
2024
Q1 | $537K | Sell |
3,917
-70
| -2% | -$9.56K | 0.3% | 89 |
|
|
2023
Q4 | $542K | Sell |
3,987
-184
| -4% | -$22.4K | 0.33% | 81 |
|
|
2023
Q3 | $510K | Sell |
4,171
-400
| -9% | -$50.9K | 0.34% | 77 |
|
|
2023
Q2 | $580K | Sell |
4,571
-128
| -3% | -$16.6K | 0.37% | 73 |
|
|
2023
Q1 | $607K | Hold |
4,699
| – | – | 0.41% | 73 |
|
|
2022
Q4 | $617K | Sell |
4,699
-498
| -10% | -$64.4K | 0.42% | 73 |
|
|
2022
Q3 | $608K | Hold |
5,197
| – | – | 0.43% | 71 |
|
|
2022
Q2 | $611K | Hold |
5,197
| – | – | 0.37% | 74 |
|
|
2022
Q1 | $677K | Sell |
5,197
-400
| -7% | -$52.1K | 0.33% | 77 |
|
|
2021
Q4 | $854K | Hold |
5,597
| – | – | 0.38% | 66 |
|
|
2021
Q3 | $905K | Sell |
5,597
-50
| -0.9% | -$8.41K | 0.41% | 63 |
|
|
2021
Q2 | $924K | Hold |
5,647
| – | – | 0.4% | 62 |
|
|
2021
Q1 | $850K | Sell |
5,647
-190
| -3% | -$30.2K | 0.39% | 62 |
|
|
2020
Q4 | $884K | Sell |
5,837
-350
| -6% | -$50K | 0.51% | 57 |
|
|
2020
Q3 | $838K | Buy |
6,187
+100
| +2% | +$13.6K | 0.54% | 54 |
|
|
2020
Q2 | $832K | Hold |
6,087
| – | – | 0.57% | 54 |
|
|
2020
Q1 | $656K | Sell |
6,087
-50
| -0.8% | -$5.76K | 0.53% | 57 |
|
|
2019
Q4 | $740K | Sell |
6,137
-125
| -2% | -$13.9K | 0.47% | 63 |
|
|
2019
Q3 | $623K | Hold |
6,262
| – | – | 0.44% | 67 |
|
|
2019
Q2 | $683K | Buy |
6,262
+364
| +6% | +$38.7K | 0.5% | 66 |
|
|
2019
Q1 | $659K | Sell |
5,898
-90
| -2% | -$9.87K | 0.51% | 65 |
|
|
2018
Q4 | $577K | Hold |
5,988
| – | – | 0.51% | 61 |
|
|
2018
Q3 | $730K | Sell |
5,988
-144
| -2% | -$17K | 0.54% | 61 |
|
|
2018
Q2 | $673K | Buy |
6,132
+150
| +3% | +$16K | 0.54% | 64 |
|
|
2018
Q1 | $639K | Sell |
5,982
-175
| -3% | -$19.4K | 0.51% | 64 |
|
|
2017
Q4 | $657K | Sell |
6,157
-230
| -4% | -$24.6K | 0.52% | 63 |
|
|
2017
Q3 | $692K | Sell |
6,387
-225
| -3% | -$24K | 0.58% | 64 |
|
|
2017
Q2 | $683K | Buy |
+6,612
| New | +$651K | 0.61% | 62 |
|
Other funds holding IBB
CB
Abbot Financial Management's IBB Position: Q1 2026 in Review
Abbot Financial Management held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 3,419 shares worth $577K. The position accounts for 0.24% of the portfolio, ranked #99.
Abbot Financial Management first reported a position in IBB in Q2 2017 and has held it in 36 quarters since. The position peaked at $924K in Q2 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Abbot Financial Management held 3,419 shares of iShares Biotechnology ETF worth $577K as of Q1 2026.
- Abbot Financial Management left its iShares Biotechnology ETF share count unchanged in Q1 2026.
- iShares Biotechnology ETF made up 0.24% of Abbot Financial Management's portfolio in Q1 2026, its #99 holding.
- Abbot Financial Management first reported a position in iShares Biotechnology ETF in Q2 2017 and has held it in 36 quarters since.
- Abbot Financial Management's iShares Biotechnology ETF position peaked at $924K in Q2 2021.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Abbot Financial Management's 13F filing for Q1 2026, filed 13 May 2026.